Visit the Exhibit Hall

Session Summary

S&OP – Eliminating Chaos and Driving Cross-Functional Engagement

Learning Objectives

1. Demonstrate an understanding of the role of Demand, Supply, Sales, and Operations planning in complex supply chains.
2. Evaluate specific examples of how Tissue Recovery planning fits into standard S&OP cycles
3. Describe the set of processes involved in Sales & Operations Planning, and establish the need for a S&OP process approach to bring about organizational transformation and cross-functional collaboration.

Mark Mullersman, Six Sigma Black Belt, DIrector of Commercial Operations

Heather Germany, CTBS / Lean Black Belt, Vice President Quality Engineering and Lean

Session Summary

It is our goal to honor the tissue donor’s gift, to maximize donation. Coordinating a multiple tissue type recovery can present challenges, and opportunities to excel. This session will cover some of the challenges, solutions and opportunities that come with the recovery of multiple tissue type recoveries, especially the lower extremity. Join subject matter experts as we come together, to work together, to make every donation happen.

Learning Objectives

1. Board overview of how to make a multiple tissue type recovery happen.
2. Discussion of challenges to a multiple tissue type recovery, and how those can be opportunities for recovery staff to excel and aquire new skills.
3. Speakers representing the nerve, vascular and musculoskeletal tissue components will provide basic requirements of recovered tissue sent to them. Highlighting ideal recoveries versus acceptable recoveries, which may be necessary to make multiple tissue ty
4. Due to the limited time for Q&A, we encourage the participant to continue the discussion with the individual processor trainer in the panel.

Megan Soceka, BS, CTBS, Education Director

Edmundo Ferreol, MD, CTBS, Sr. Mgr. Technical Education and Training

Michael Gilbert, MBA, CTBS, Technical Trainer

Jeremy Douglas, BS, CTBS, Tissue Services Trainer

Session Summary

With C-section rates starting to trend downward nationally, birth tissue recovery agencies need to plan and strategize how to maintain a successful birth tissue program. This presentation will discuss the challenges facilities may face, including working with hospital pathology departments and some options to consider in maintaining a successful program.

Learning Objectives

1. Discuss national C-Section rates and trends from previous years regarding births.
2. Understand challenges associated with placentias requiring pathology evaluation.
3. Provide options to consider to ensure changes in C-section rates as well as births in general will not significantly impact birth tissue donation.

Hannis W. Thompson, MD, Medical Director

Session Summary

Aftercare communication during donor family approach conversations begins to set expectations for donor families as to what happens after the donation occurs. A discussion of best practices will help donation professionals manage and set realistic expectations should a family express a desire to write to or meet the recipients of their gifted tissues. Additionally this session will provide guidance in regards to working with families who decide that they do not want to participate in ongoing aftercare communication following the authorization/disclosure conversation.

Learning Objectives

1. Explain why it is important to talk to families about aftercare communication as part of the family approach conversation
2. List at least two goals of ongoing aftercare programs
3. Discuss why it is important to set realistic expectation concerning a donor family's ability to connect with their potential recipients.
4. Identify best practices for donor families that do not want to participate in aftercare communication following donation.

Pamela L. Albert, RN, BSN, CPTC, Sr. Director TDS Resource Development & Aftercare Services

Session Summary

Provide attendees with an understanding of the utilization of new infectious disease testing methodologies and processes to provide pre-procurement screening for tissue donors. The presentation will review the business case, the change in processes, and the impact of pre-procurement infectious disease testing results being available prior to tissue procurement in one OPO's environment.

Linda Martin, CTBS, Vice President, Tissue and Support Services

Session Summary

Few know what a Bioskills Lab is. Even fewer may know what a NADO is. What are these industry entities, what do they do, and how do they interact to influence innovations in research, development, and training, in a variety of areas, including transplantation? In this session, the presenters will discuss the answers to these questions and highlight the immense importance of the partnership between NADOs and Bioskills Laboratories, and much more.

Learning Objectives

1. Introduce and educate individuals on the pre-clinical roles in patient healthcare
2. Summarize how research, development and training prior to patient having any contact with any implant is utilized within the bioskills community
3. Discuss what is a NADO and how they are involved within the bioskills community.

Kelley Bennett, BSHS, CTBS, Director of Clinical partnerships

Robin Bozarth, CTBS, Medical Education, Compliance and Quality Assurance Manager

Session Summary

In this session, Dylan and James will review some top techniques for attracting and identifying stellar performers during your hiring practices, as well as how to retain them once you have them within your workplace. If you don’t think you have the time or funds to spend on methods to retain your top talent, you certainly don’t have the resources to utilize in search of their replacements!

Learning Objectives

1. Identify and screen for worthy candidates from a hiring pool
2. Analyze their current retention strategies
3. Realize the value of effective strategies
4. Implement effective changes to ensure that they are not only hiring quality candidates, but are keeping their best performers and are not needlessly wasting resources on ineffective programs

Dylan Kimzey, Quality Assurance Manager

James S. Bardsley, BS, LFD, CTBS, Director of Operations, CSO

Session Summary

In this recorded interview with key personnel of AATB-accredited Non-Transplant Donation Organizations (NADOs), panelists and the moderator will be discussing where things went well and where things could've gone better while handling the various--and sometimes unique--concerns and crises caused by the COVID-19 pandemic. There will be time at the recordings' end for Q&A with the audience live via instant-message chatroom or via post-session email.

Learning Objectives

1. Gain valuable insight from NADOs' and other participants' unique perspectives
2. Learn from the challenges that NADOs and other participants have, and continue to, face
3. Share experiences among each other and the panelists
4. Apply knowledge from the lessons learned to their own organizations

James S. Bardsley, BS, LFD, CTBS, Director of Operations, CSO

Robin Bozarth, CTBS, Medical Education, Compliance and Quality Assurance Manager

Amanda Rodgers, BS, Vice President of Operations

Have you ever had the feeling that your change management efforts would be perfect if it wasn’t for the pesty people involved with the change? Don’t worry! You are not alone; People are the #1 barrier to effective change management. In this session, you will learn why change management efforts stall and what you, as the change manager, can do at the individual and organization level to keep the change implementation moving forward. We will review effective communication because change management is communication management, explore the Kubler-Ross change adoption model, and dive into the Dialogic Change Model to create an action plan for your organization.

Learning Objectives:

1. Understand the linear and interactive communication models and how context can influence your change management efforts

2. Recognize stages of change acceptance and what you can do to facilitate these stages

3. Develop a specific, tangible action plan for managing individual and organizational change

Session Summary

Risk management is an important process for all organizations, especially in tissue banking! Effective risk management means acting proactively to control future outcomes by mitigating the impact risks have on your organization's growth and potential survival. Let's come together and share best practices on risk management, the identification, analysis, and response to risk factors.

Learning Objectives

1. What is risk managment.
2. Who cares about risk management.
3. Why risk management matters.
4. What do I do......Let's put it into action!

Jennifer Drago, CTBS, CQM/OE, CQA,

Jackie Warn, MBA, CMQOE, Chief Quality Officer

Kathryn D. McIver, DBA, MBA, MBB, Founder

We all seek to improve our company’s efficiency and relationship with partners. This presentation will provide an overview of an email-based approach for Electronic Referrals. It will be particularly helpful for call centers focused on screening for processor needs. This session aims to share company and customer impact as well as statistical analysis from a system in action over the past four years.

Learning Objectives:

• Learn the mechanics of an email-based approach to Electronic Referrals
• Understand the impact (positive and negative) on recovery agency and tissue processor
• Appreciate the option of a secure and cost-effective alternative to web-based referral systems

Nikki M. Brooks, BA, CTBS, GC-C, Director, Donor Referral Center

Birth tissue can be created using various genetic parents. Concerns have come up in the industry regarding the donation of birth tissue if IVF, donor or surrogate are outlined in the pregnancy history. This talk aims to help attendees understand the history of reproductive tissue donation, what screening/testing may have been completed on the reproductive tissue donors, and the safety of their use.

Learning Objectives:

• Distinguish between various types of reproductive donors that may be used as birth tissue donations are evaluated for eligibility
• Understand current regulatory screening/testing requirements for reproductive donors as it relates to birth tissue donation
• Reflect on case study examples related to reproductive donors being used with birth tissue donation

W. Brent Hazelrigg, MS, President\CEO

Session Summary

Creating Sacred Spaces of Care: Temporary Guardian of the Soul presentation will help to raise awareness so that participants will gain a broader understanding of how to companion bereaved families. In addition, participants will also gain a broader understanding of social trends and how they affect healthy mourning. The participants will gain insights to some barriers that have discouraged African Americans families from participating in programs sponsored by medical entities. Lastly, participants will gain knowledge on how to address general distrust through cultural competency. This presentation will also focus on ways to attract the African American community to programs for grief aftercare.

Learning Objectives

1. Participants will gain a broader understanding of companioning the bereaved
2. Participants will be introduced to the social trends that affect healthy mourning.
3. Participants will gain insights to some barriers that discourage African Americans families from participating in programs sponsored by medical entities
4. Participants will gain knowledge on how to address general distrust and attract people of color to programs of aftercare grief.

Reuben D. Wright, BS, Donor Family Services Coordinator

Session Summary

This session is a call to action intended for industry professionals to analyze repeated AATB findings and determine contributing causal factors. Utilizing Public Information from FDA’s Office of Regulatory Affairs Inspection Observations as aggregated from 483’s a Venn Diagram will be constructed referencing AATB and FDA Inspections.

Learning Objectives

1. Assess if AATB standards are in alignment with industry practice.
2. Breakdown trends to determine contributing factors of non-compliance.
3. Evaluate inspectional findings between FDA and AATB have commonality.

Beverly Bliss, MBA, CTBS, Chief Technical Officer

Kip J. Hanks, Director of Regulatory and Governmental Affairs